CARv3-TEAM-E T Cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CARv3-TEAM-E T Cells, covering 2026-02-04 to 2026-02-04. Get the full timeline:
Most recent: Clinical Trial Update: CARv3-TEAM-E T Cells in Glioblastoma [Phase 1]